Role of angiogenic factors/cell adhesion markers in serum of cirrhotic patients with hepatopulmonary syndrome

Liver International

Volumn 35, Issue 5, 2015, Pages 1499-1507

  Raevens, Sarah ^a   Coulon, Stephanie ^a   Van Steenkiste, Christophe ^a,b   Colman, Roos ^c   Verhelst, Xavier ^a   Van Vlierberghe, Hans ^a   Geerts, Anja ^a   Perkmann, Thomas ^d   Horvatits, Thomas ^d   Fuhrmann, Valentin ^d   Colle, Isabelle ^c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Maria Middelares Hospital   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; Cirrhosis; Hepatopulmonary syndrome; ICAM3; VCAM1

Indexed keywords

ANGIOGENIC FACTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 3; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN D; CELL ADHESION MOLECULE; ICAM3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CELL ADHESION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAS EXCHANGE; HEPATOPULMONARY SYNDROME; HUMAN; KRUSKAL WALLIS TEST; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OUTPATIENT CARE; PATHOGENESIS; PRACTICE GUIDELINE; PREDICTIVE VALUE; SCREENING; VASODILATATION; AGED; BLOOD; COMPLICATION; STATISTICAL MODEL;

AGED; ANTIGENS, CD; BIOMARKERS; CELL ADHESION MOLECULES; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84927689040     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12579     Document Type: Article

References (30)

1. Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome - a liver-induced lung vascular disorder. N Engl J Med 2008; 358: 2378-87.
2. Fuhrmann V, Madl C, Mueller C, et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 2006; 131: 69-75.
3. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 1994; 105: 1528-37.
4. Schenk P, Schoniger-Hekele M, Fuhrmann V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003; 125: 1042-52.
5. Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest 1990; 97: 1165-70.
6. Stoller JK, Lange PA, Westveer MK, et al. Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med 1995; 163: 133-8.
7. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005; 41: 1122-9.
8. Singh C, Sager JS. Pulmonary complications of cirrhosis. Med Clin North Am 2009;93:871-83, viii.
9. Coulon S, Heindryckx F, Geerts A, et al. Angiogenesis in chronic liver disease and its complications. Liver Int 2011; 31: 146-62.
10. Imhof BA, Aurrand-Lions M. Angiogenesis and inflammation face off. Nat Med 2006; 12: 171-2.
11. Grace JA, Angus PW. Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment. J Gastroenterol Hepatol 2013; 28: 213-9.
12. Herve P, Le PJ, Sztrymf B, et al. Pulmonary vascular abnormalities in cirrhosis. Best Pract Res Clin Gastroenterol 2007; 21: 141-59.
13. Taille C, Cadranel J, Bellocq A, et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 2003; 75: 1482-9.
14. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 2004; 24: 861-80.
15. Abrams GA, Sanders MK, Fallon MB. Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl 2002; 8: 391-6.
16. Deibert P, Allgaier HP, Loesch S, et al. Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry. BMC Gastroenterol 2006; 6: 15.
17. Voiosu A, Voiosu T, Stanescu CM, et al. Novel predictors of intrapulmonary vascular dilatations in cirrhosis: extending the role of pulse oximetry and echocardiography. Acta Gastroenterol Belg 2013; 76: 241-5.
18. Zamirian M, Aslani A, Shahrzad S. Left atrial volume: a novel predictor of hepatopulmonary syndrome. Am J Gastroenterol 2007; 102: 1392-6.
19. Pouriki S, Alexopoulou A, Chrysochoou C, et al. Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndrome. Liver Int 2011; 31: 1388-94.
20. Ferreira PP, Camara EJ, Paula RL, et al. Prevalence of hepatopulmonary syndrome in patients with decompensated chronic liver disease and its impact on short-term survival. Arq Gastroenterol 2008; 45: 34-7.
21. Schenk P, Fuhrmann V, Madl C, et al. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002; 51: 853-9.
22. Krowka MJ, Wiseman GA, Burnett OL, et al. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99 m)Tc MAA lung scanning. Chest 2000; 118: 615-24.
23. Vachiery F, Moreau R, Hadengue A, et al. Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterations. J Hepatol 1997; 27: 492-5.
24. Verkarre V, de Patey-Mariaud SN, Vazeux R, et al. ICAM-3 and E-selectin endothelial cell expression differentiate two phases of angiogenesis in infantile hemangiomas. J Cutan Pathol 1999; 26: 17-24.
25. Zhang ZJ, Yang CQ. Progress in investigating the pathogenesis of hepatopulmonary syndrome. Hepatobiliary Pancreat Dis Int 2010; 9: 355-60.
26. Thenappan T, Goel A, Marsboom G, et al. A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am J Respir Crit Care Med 2011; 183: 1080-91.
27. Zhang J, Luo B, Tang L, et al. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology 2009; 136: 1070-80.
28. Liu L, Liu N, Zhao Z, et al. TNF-alpha neutralization improves experimental hepatopulmonary syndrome in rats. Liver Int 2012; 32: 1018-26.
29. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-60.
30. Zhang J, Yang W, Luo B, et al. The role of CX(3)CL1/CX(3)CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. J Hepatol 2012; 57: 752-8.